Skip to content
MedsAcross

Medicine

Cipro kit

Ciprofloxacin · Bayer HealthCare Pharmaceuticals
Available on requestPrescription onlyUS FDA

Cipro kit is a prescription medicine containing Ciprofloxacin, marketed by Bayer HealthCare Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing. Store at 20° to 25°C (68° to 77°F), excursions…

Key facts

Active ingredient (INN)
Ciprofloxacin
Brand
Cipro
Dosage form
Kit
Packs
1 kit
Marketing authorisation holder
Bayer HealthCare Pharmaceuticals
Manufacturer
Bayer HealthCare Pharmaceuticals
Origin register
US FDA, United States
Storage
Protect from freezing. Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Strengths Total volume after reconstitution Ciprofloxacin Concentration Ciprofloxacin contents per bottle NDC Code 5% 100 mL 250 mg/5 mL 5,000 mg 50419-777-01 10% 100 mL 500 mg/5 mL 10,000 mg 50419-773-01 Store microcapsules and diluent below 25°C (77°F), excursions are permitted from…
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01MA02 Ciprofloxacin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
26 September 1997
Identifiers
RxCUI 197511, 205769, 205770 +5DailyMed set ID 888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0NDC 50419-773, 50419-777Application NDA020780

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 kit in 1 kit * 100 mL in 1 bottle, glass * 100 mL in 1 bottle, glass50419-773-01Bayer HealthCare Pharmaceuticals26 September 1997
1 kit in 1 kit * 100 mL in 1 bottle, glass * 100 mL in 1 bottle, plastic50419-777-01Bayer HealthCare Pharmaceuticals26 September 1997

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 October 1987Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Ciprofloxacin

Clinical summary

Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated, among other approved uses. MedsAcross supplies Ciprofloxacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ciprofloxacin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Cipro kit for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.